NR4A1 and breast cancer: Based on the molecular status of estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor-2 (HER2), BC is categorized into 3 major subtypes: hormone receptor positive, HER2 positive, and triple-negative tumors, which lack all 3 molecular markers [49].